Skip to main content

Lab2Launch Companies

Meet the Emory-affiliated life science ventures that have participated in Lab2Launch.

Apply to Lab2Launch

Current Residents

Lab2Launch residents are early-stage life science ventures with a qualifying Emory affiliation and commercialization activity related to Emory intellectual property. Current residents receive access to wet lab space, office space, shared infrastructure, and entrepreneurial support within Emory's research innovation ecosystem.

Learn more about our companies below:

Cambium Therapeutics for cancer

This is the Cambium logo

MIGRA Therapeutics Drug delivery platforms for targeted therapy of drug-resistant cancers

This is the logo for MIGRA

Pneumotactix Development of therapeutic enzymes against bacterial pathogens

This is the logo for PneumotaciX

Emtherapro

Diagnosis and treatment of neurodegenerative diseases. Learn more here.

Emtherapro logo

Corami Biotech

Targeted Cardiac Therapeutic Delivery. Learn more here.

CorAmi Biotech logo

5M Biomed

Novel bio-inspired magnetic nano-materials and molecularly targeted imaging methods. Learn more here.

5M Biomed logo

KadisBio Innovative Cell Therapy for Cardiovascular Disease

KadisBio logo

Apply Today

Lab2Launch is currently vetting new applicants for residency. If you would like to learn more about the program and the application process, visit our incubator page.



Alumni and Inaugural Residents

The companies below are recognized as former residents and early participants in the Lab2Launch community.

Learn more about the companies below:

Camerad Point-of-care patient photography integrated with medical imaging (Diagnostic)

This is the logo for Camerad

OncoSpherix

Advanced drugs for advanced cancer. Learn more here.  

OncoSpherix logo

Uppergate Biopharma

Development of novel bio-inspired magnetic nanomaterials and molecularly targeted diseases.